Skip to main content
. 2019 Dec 27;14(1):8–16. doi: 10.30699/IJP.14.1.8

Figure 1.

Figure 1

Melanoma cells showed diffuse cytoplasmic BRAF V600E immunoreactivity (score3+, X200 magnified)